T. Kasama et al., INTERLEUKIN-10 EXPRESSION AND CHEMOKINE REGULATION DURING THE EVOLUTION OF MURINE TYPE-II COLLAGEN-INDUCED ARTHRITIS, The Journal of clinical investigation, 95(6), 1995, pp. 2868-2876
In the enclosed study we have examined the expression and contribution
of specific chemokines, macrophage inflammatory protein 1 alpha (MIP-
1 alpha) and macrophage inflammatory protein 2 (MIP-2), and interleuki
n 10 (IL-10) during the evolution of type II collagen-induced arthriti
s (CIA). Detectable levels of chemotactic cytokine protein for MIP-1 a
lpha and MIP-2 were first observed between days 32 and 36, after initi
al type II collagen challenge, while increases in IL-10 were found bet
ween days 36 and 44. CIA mice passively immunized with antibodies dire
cted against either MIP-1 alpha or MIP-2 demonstrated a delay in the o
nset of arthritis and a reduction of the severity of arthritis. On the
contrary, CIA mice receiving neutralizing anti-IL-10 antibodies demon
strated an acceleration of the onset and an increase in the severity o
f arthritis. Interestingly, anti-IL-10 treatment, increased the expres
sion of MIP-1 alpha and MIP-2, as well as increased myeloperoxidase (M
PO) activity and leukocyte infiltration in the inflamed joints. These
data suggest that MIP-1 alpha and MIP-2 play a crucial role in the ini
tiation and maintenance, while IL-10 appears to play a regulatory role
during the development of experimental arthritis.